Back

An external validation of DOAC score in patients with atrial fibrillation following transcatheter aortic valve replacement

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Risk assessment and prognosis in atrial fibrillation Oral Anticoagulation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Yoshihiro Harano

Gifu (Japan)

5 More presentations in this session

Presentation thumbnail
Invasive haemodynamic assessment shows the obesity-HFpEF phenotype is common amongst patients with symptomatic AF
Doctor J. Ariyaratnam (Adelaide, AU)
Abstract Slides Video
Presentation thumbnail
The association of NT-proBNP levels in atrial fibrillation patients and 3-year risk of heart hospitalization and death
Doctor K. Szummer (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Ambulatory polygraphy as a screening tool for obstructive sleep apnea in combination with semi-continuous rhythm monitoring in patients with atrial fibrillation: a pilot study
Miss R. Onder (Hasselt, BE)
Abstract Slides Video
Presentation thumbnail
Risk and causes of hospital admission in patients with atrial fibrillation on treatment with oral anticoagulants
Doctor A. Pannunzio (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Novel predictor of thrombosis after left atrial appendage closure -Neutrophil to Lymphocyte Ratio (NLR), platelet to LymPhocyte Ratio (PLR), and Lymphocyte to Monocyte Ratio (LMR)-.
Doctor S. Ryuzaki (Chiba, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Risk assessment and prognosis in atrial fibrillation

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
The usefulness of the direct oral anticoagulant score for predicting bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: a multicenter study.
thumbnail
Congress Presentation
Application of DOAC Score for the risk-stratification of major bleeding in patients with venous thromboembolism on direct oral anticoagulants: insight from the COMMAND VTE Registry-2
thumbnail
Congress Presentation
Bleeding risk in all-comer TAVI patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources